156 related articles for article (PubMed ID: 2026500)
21. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
[TBL] [Abstract][Full Text] [Related]
22. Localization of 99mTc-diphosphonates in newly formed bone matrix as a measure of bone lesion detectability.
Schuemichen C; Krause T; Umbach G; Wolff T
Nuklearmedizin; 1988 Feb; 27(1):8-11. PubMed ID: 3368337
[TBL] [Abstract][Full Text] [Related]
23. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
[No Abstract] [Full Text] [Related]
24. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning].
Yang JS
Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062
[No Abstract] [Full Text] [Related]
25. 99Tcm-citrate: a new bone imaging radiopharmaceutical.
Bhatnagar A; Mishra P; Sharma R; Chuttani K; Chakravarty K; Jain CM; Mondal A; Chopra MK; Gupta A
Nucl Med Commun; 1999 Nov; 20(11):1067-76. PubMed ID: 10572918
[TBL] [Abstract][Full Text] [Related]
26. A micro-autoradiographical study of the localization of 99mTc(Sn)-MDP and 99mTc-MDP in undecalcified bone sections.
Savelkoul TJ; Visser WJ; Oldenburg SJ; Duursma SA
Eur J Nucl Med; 1986; 11(11):459-62. PubMed ID: 3086099
[TBL] [Abstract][Full Text] [Related]
27. 99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. A visual and quantitative comparison.
Lantto T; Vorne M; Mokka R; Vähätalo S
Acta Radiol; 1987; 28(5):631-3. PubMed ID: 2960361
[TBL] [Abstract][Full Text] [Related]
28. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model.
Louw WK; Dormehl IC; van Rensburg AJ; Hugo N; Alberts AS; Forsyth OE; Beverley G; Sweetlove MA; Marais J; Lötter MG; van Aswegen A
Nucl Med Biol; 1996 Nov; 23(8):935-40. PubMed ID: 9004281
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.
Lam AS; Puncher MR; Blower PJ
Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310
[TBL] [Abstract][Full Text] [Related]
31. Extraosseous accumulation of bone scanning agents in malignant brain tumors: comparison to semi-quantitative evaluation with 99mTc SPECT/201Tl SPECT and histological findings.
Suzuki A; Togawa T; Kuyama J; Nakahara T; Iuchi T; Oga M; Osato K; Takenouchi T
Ann Nucl Med; 2003 Jul; 17(5):387-92. PubMed ID: 12971637
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of accumulation of 99mTc-MDP to bone: correlation of in vivo data with in vitro data.
Okamoto YM
Radiat Med; 1997; 15(4):209-15. PubMed ID: 9311035
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and imaging evaluation of (99m)Tc-HBIDP as a potential bone imaging agent.
Qiu L; Lin J; Nan B; Lv G; Cheng W
Pak J Pharm Sci; 2015 May; 28(3):815-8. PubMed ID: 26004712
[TBL] [Abstract][Full Text] [Related]
34. Activity in the gastrointestinal tract after administration of bone-seeking radiopharmaceuticals. Experimental studies in mice.
Cronhjort M; Jonsson C; Nilsson SO; Garmelius B; Jacobsson H
Acta Radiol; 1996 Sep; 37(5):785-90. PubMed ID: 8915294
[TBL] [Abstract][Full Text] [Related]
35. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
Brenner W; Kampen WU; Kampen AM; Henze E
J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521
[TBL] [Abstract][Full Text] [Related]
36. Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)?
Frühling J; Verbist A; Balikdjian D
Nucl Med Commun; 1986 Jun; 7(6):415-25. PubMed ID: 3748485
[TBL] [Abstract][Full Text] [Related]
37. Clinical comparison of bone scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP.
Bergqvist L; Brismar J; Cederquist E; Darte L; Naversten Y; Palmer J
Acta Radiol Diagn (Stockh); 1984; 25(3):217-23. PubMed ID: 6236672
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of malignant and degenerative benign bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy.
Sharma R; Mondal A; Bhatnagar A; Chakravarty KL; Mishra P; Chopra MK; Rawat HS; Kashyap R
Clin Nucl Med; 1998 Nov; 23(11):758-63. PubMed ID: 9814564
[TBL] [Abstract][Full Text] [Related]
39. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
[TBL] [Abstract][Full Text] [Related]
40. The visualization of femoral vessels in delayed bone scans--a sign of arteriosclerosis? A comparison of 99mTc-MDP and 99mTc-DPD.
Lantto T; Järvi K; Toivio I; Vähätalo S; Vorne M
Eur J Nucl Med; 1989; 15(5):265-8. PubMed ID: 2759127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
